Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial

Matti J Tikkanen, Michael Szarek, Rana Fayyad, Ingar Holme, Nilo B Cater, Ole Faergeman, John J P Kastelein, Anders G Olsson, Mogens Lytken Larsen, Christina Lindahl, Terje R Pedersen

Research output: Contribution to journalJournal articleResearchpeer-review

Fingerprint Dive into the research topics of 'Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences